Diabetes and obesity drugs also lead to large reductions in adverse cardiovascular events, and the benefits aren’t just down ...

It's yet another perk of these medications.

Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

If you're looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) ...

Popular weight-loss drugs such as Ozempic, Wegovy, and Mounjaro may do more than help people shed pounds. New research suggests these GLP-1 medications could also help protect the heart after a heart ...

GLP-1 drugs may help boost heart attack recovery by lowering the risk of major complications, an animal study suggests.

NEW YORK, March 11, 2026 /PRNewswire/ -- Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients ...

For years, researchers have suspected that a hormone called relaxin could be an effective treatment for certain cardiovascular diseases. It helps counteract scarring (fibrosis), prevents veins and ...

Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

HealthDay News — In middle-aged and older adults, anticholinergic drug burden is associated with an increased risk for ...